Ovarian High Grade Serous Adenocarcinoma

general

A rapidly growing serous adenocarcinoma that arises from the ovary. It is characterized by the presence of high-grade cytologic features and frequent mitotic figures.

80

Centers

297

Active Trials

$1.1B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Ovarian High Grade Serous Adenocarcinoma(80)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.9
2
NCI Comprehensive
High-Volume Research Center
72.3
371.4
4
High-Volume Research Center
71.4
5
Active Research Program
69.9
6
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
69.9
7
Active Research Program
69.9
8
NCI Comprehensive
Active Research Program
66.6
9
NCI Comprehensive
Active Research Program
66.6
10
NCI Comprehensive
Active Research Program
66.6
11
NCI Comprehensive
Active Research Program
66.6
12
NCI Comprehensive
Active Research Program
66.6
13
Active Research Program
66.6
14
NCI Comprehensive
Active Research Program
66.6
15
Active Research Program
66.6
16
NCI Comprehensive
Active Research Program
59.4
17
NCI Comprehensive
Active Research Program
59.4
18
NCI Comprehensive
Active Research Program
59.4
19
NCI Comprehensive
Active Research Program
59.4
20
NCI Comprehensive
Active Research Program
59.4
21
NCI Comprehensive
Active Research Program
59.4
22
NCI Comprehensive
Active Research Program
59.4
23
NCI Clinical
Active Research Program
59.4
24
NCI Comprehensive
Active Research Program
59.4
25
NCI Comprehensive
Active Research Program
59.4
26
Active Research Program
59.4
27
Active Research Program
59.4
28
NCI Comprehensive
Active Research Program
59.4
29
Active Research Program
59.4
3059.4
31
Active Research Program
59.4
32
NCI Comprehensive
Active Research Program
47.1
33
NCI Comprehensive
Active Research Program
47.1
34
NCI Comprehensive
Active Research Program
47.1
35
NCI Comprehensive
Active Research Program
47.1
36
NCI Comprehensive
Active Research Program
47.1
37
NCI Comprehensive
Active Research Program
47.1
38
NCI Comprehensive
Active Research Program
47.1
39
NCI Comprehensive
Active Research Program
47.1
40
NCI Comprehensive
Active Research Program
47.1
41
NCI Clinical
Active Research Program
47.1
42
NCI Comprehensive
Active Research Program
47.1
43
NCI Comprehensive
Active Research Program
47.1
44
NCI Comprehensive
Active Research Program
47.1
45
NCI Comprehensive
Active Research Program
47.1
46
NCI Clinical
Active Research Program
47.1
47
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
47.1
48
NCI Comprehensive
Active Research Program
47.1
49
NCI Clinical
Active Research Program
47.1
5047.1
51
Active Research Program
47.1
52
Active Research Program
47.1
53
Active Research Program
47.1
54
Active Research Program
47.1
55
Active Research Program
47.1
56
Active Research Program
47.1
57
NCI Comprehensive
Contributing Research Center
34.2
58
NCI Comprehensive
Contributing Research Center
34.2
59
NCI Comprehensive
Contributing Research Center
34.2
60
NCI Comprehensive
Contributing Research Center
34.2
61
NCI Comprehensive
Contributing Research Center
34.2
62
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Contributing Research Center
34.2
63
NCI Comprehensive
Contributing Research Center
34.2
64
NCI Comprehensive
Contributing Research Center
34.2
65
NCI Comprehensive
Contributing Research Center
34.2
66
Contributing Research Center
34.2
67
NCI Clinical
Contributing Research Center
34.2
68
NCI Comprehensive
Contributing Research Center
34.2
69
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Contributing Research Center
34.2
70
NCI Basic_laboratory
Contributing Research Center
34.2
71
Contributing Research Center
34.2
72
Contributing Research Center
34.2
73
Contributing Research Center
34.2
74
Contributing Research Center
34.2
75
NCI Comprehensive
28.5
76
NCI Comprehensive
77
NCI Clinical
78
79
80

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →